Attached files

file filename
10-Q - FORM 10-Q - CYTOKINETICS INCf59630e10vq.htm
EX-3.2 - EX-3.2 - CYTOKINETICS INCf59630exv3w2.htm
EX-31.1 - EX-31.1 - CYTOKINETICS INCf59630exv31w1.htm
EX-10.2 - EX-10.2 - CYTOKINETICS INCf59630exv10w2.htm
EX-31.2 - EX-31.2 - CYTOKINETICS INCf59630exv31w2.htm
EXCEL - IDEA: XBRL DOCUMENT - CYTOKINETICS INCFinancial_Report.xls
         
EXHIBIT 32.1
CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18. U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
     I certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Cytokinetics, Incorporated on Form 10-Q for the quarterly period ended June 30, 2011 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Cytokinetics, Incorporated.
Dated: August 4, 2011
         
     
  /s/ Robert I. Blum    
  Robert I. Blum   
  President and Chief Executive Officer
(Principal Executive Officer) 
 
 
     
  /s/ Sharon A. Barbari    
  Sharon A. Barbari   
  Executive Vice President, Finance and
Chief Financial Officer
(Principal Financial Officer)